Arifulla Khan

4.5k total citations
58 papers, 1.7k citations indexed

About

Arifulla Khan is a scholar working on Psychiatry and Mental health, Pharmacology and Experimental and Cognitive Psychology. According to data from OpenAlex, Arifulla Khan has authored 58 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Psychiatry and Mental health, 16 papers in Pharmacology and 13 papers in Experimental and Cognitive Psychology. Recurrent topics in Arifulla Khan's work include Electroconvulsive Therapy Studies (18 papers), Treatment of Major Depression (14 papers) and Schizophrenia research and treatment (13 papers). Arifulla Khan is often cited by papers focused on Electroconvulsive Therapy Studies (18 papers), Treatment of Major Depression (14 papers) and Schizophrenia research and treatment (13 papers). Arifulla Khan collaborates with scholars based in United States, Sweden and Canada. Arifulla Khan's co-authors include Seth A. Cohen, Michael E. Thase, Björn Paulsson, William Chang, Richard H. Weisler, Wayne Macfadden, Joseph R. Calabrese, Narendra P. Singh, David L. Dünner and David Avery and has published in prestigious journals such as American Journal of Psychiatry, Neurology and Biological Psychiatry.

In The Last Decade

Arifulla Khan

55 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Arifulla Khan United States 23 852 535 396 324 155 58 1.7k
K. Behnke Denmark 19 983 1.2× 620 1.2× 480 1.2× 334 1.0× 116 0.7× 33 1.6k
Ram Shrivastava United States 16 577 0.7× 554 1.0× 443 1.1× 172 0.5× 174 1.1× 28 1.3k
Alfredo Carlo Altamura Italy 22 771 0.9× 266 0.5× 262 0.7× 471 1.5× 232 1.5× 66 1.6k
S. Hoog United States 12 857 1.0× 655 1.2× 464 1.2× 832 2.6× 192 1.2× 23 1.7k
Mark D. Fossey United States 15 1.2k 1.4× 267 0.5× 271 0.7× 649 2.0× 110 0.7× 22 1.8k
J M Perel United States 21 433 0.5× 331 0.6× 263 0.7× 450 1.4× 195 1.3× 31 1.3k
James L. Claghorn United States 21 831 1.0× 506 0.9× 355 0.9× 476 1.5× 362 2.3× 70 1.7k
Anna Åberg‐Wistedt Sweden 23 714 0.8× 379 0.7× 162 0.4× 582 1.8× 126 0.8× 38 1.7k
Steven K. Secunda United States 21 831 1.0× 289 0.5× 223 0.6× 221 0.7× 72 0.5× 33 1.2k
Joseph Mendels United States 21 448 0.5× 533 1.0× 373 0.9× 230 0.7× 263 1.7× 33 1.5k

Countries citing papers authored by Arifulla Khan

Since Specialization
Citations

This map shows the geographic impact of Arifulla Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arifulla Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arifulla Khan more than expected).

Fields of papers citing papers by Arifulla Khan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arifulla Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arifulla Khan. The network helps show where Arifulla Khan may publish in the future.

Co-authorship network of co-authors of Arifulla Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Arifulla Khan. A scholar is included among the top collaborators of Arifulla Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arifulla Khan. Arifulla Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kupiec, James W., Raymond Scott Turner, Suzanne Hendrix, et al.. (2026). Phase 3 randomized clinical trials of simufilam in mild-to-moderate Alzheimer’s disease. The Journal of Prevention of Alzheimer s Disease. 13(3). 100469–100469.
2.
3.
Schnitzer, Thomas J., Arifulla Khan, Louis Bessette, et al.. (2020). Onset and maintenance of efficacy of subcutaneous tanezumab in patients with moderate to severe osteoarthritis of the knee or hip: A 16-week dose-titration study. Seminars in Arthritis and Rheumatism. 50(3). 387–393. 15 indexed citations
4.
Thase, Michael E., Wayne Macfadden, Richard H. Weisler, et al.. (2006). Efficacy of Quetiapine Monotherapy in Bipolar I and II Depression. Journal of Clinical Psychopharmacology. 26(6). 600–609. 399 indexed citations
5.
Labellarte, Michael J., Joseph Biederman, Graham J. Emslie, et al.. (2004). Multiple-Dose Pharmacokinetics of Fluvoxamine in Children and Adolescents. Journal of the American Academy of Child & Adolescent Psychiatry. 43(12). 1497–1505. 15 indexed citations
6.
Rickels, Karl, Richard M. Mangano, & Arifulla Khan. (2004). A Double-Blind, Placebo-Controlled Study of a Flexible Dose of Venlafaxine ER in Adult Outpatients With Generalized Social Anxiety Disorder. Journal of Clinical Psychopharmacology. 24(5). 488–496. 70 indexed citations
7.
Khan, Arifulla, G. Virginia Upton, Richard L. Rudolph, Richard Entsuah, & Steven M. Leventer. (1998). The Use of Venlafaxine in the Treatment of Major Depression and Major Depression Associated With Anxiety. Journal of Clinical Psychopharmacology. 18(1). 19–25. 66 indexed citations
8.
Rosenfarb, Irwin S., et al.. (1998). Dependency and self‐criticism in bipolar and unipolar depressed women. British Journal of Clinical Psychology. 37(4). 409–414. 49 indexed citations
9.
Singh, Narendra, Henry Lai, & Arifulla Khan. (1995). Ethanol-induced single-strand DNA breaks in rat brain cells. Mutation Research/Genetic Toxicology. 345(3-4). 191–196. 55 indexed citations
10.
Singh, Narendra P. & Arifulla Khan. (1995). Acetaldehyde: genotoxicity and cytotoxicity in human lymphocytes. Mutation Research/DNA Repair. 337(1). 9–17. 99 indexed citations
11.
Rosenfarb, Irwin S., Joseph Becker, & Arifulla Khan. (1994). Perceptions of parental and peer attachments by women with mood disorders.. Journal of Abnormal Psychology. 103(4). 637–644. 28 indexed citations
12.
Khan, Arifulla, et al.. (1993). Can ECT-induced cognitive effects be altered pharmacologically?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 17(6). 861–873. 13 indexed citations
13.
Khan, Arifulla, et al.. (1993). Low‐Dose Thyrotropin‐Releasing Hormone Effects in Cognitively Impaired Alcoholics. Alcoholism Clinical and Experimental Research. 17(4). 791–796. 6 indexed citations
14.
Khan, Arifulla, et al.. (1991). Is a single tricyclic antidepressant trial an active treatment for psychotic depression?. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 15(6). 765–770. 7 indexed citations
15.
Avery, David, Arifulla Khan, Stephen R. Dager, et al.. (1991). Morning or evening bright light treatment of winter depression? The significance of hypersomnia. Biological Psychiatry. 29(2). 117–126. 57 indexed citations
16.
Cohen, Seth A. & Arifulla Khan. (1990). Antipsychotic effect of milieu in the acute treatment of schizophrenia. General Hospital Psychiatry. 12(4). 248–251. 16 indexed citations
17.
Vitiello, Michael V., Patricia N. Prinz, David Avery, et al.. (1990). Sleep is undisturbed in elderly, depressed individuals who have not sought health care. Biological Psychiatry. 27(4). 431–440. 23 indexed citations
18.
Khan, Arifulla, et al.. (1988). Psychotic and nonpsychotic depression: comparison of response to ECT.. PubMed. 49(3). 97–9. 19 indexed citations
19.
Cohen, Seth A., et al.. (1988). Hospitalization effect in acute mania. General Hospital Psychiatry. 10(2). 138–141. 6 indexed citations
20.
Cohen, Seth A. & Arifulla Khan. (1987). Adjunctive Benzodiazepines in Acute Schizophrenia. Neuropsychobiology. 18(1). 9–12. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by K. Behnke Breakdown of academic impact, for papers by Ram Shrivastava Breakdown of academic impact, for papers by Alfredo Carlo Altamura Breakdown of academic impact, for papers by S. Hoog Breakdown of academic impact, for papers by Mark D. Fossey Breakdown of academic impact, for papers by J M Perel Breakdown of academic impact, for papers by James L. Claghorn Breakdown of academic impact, for papers by Anna Åberg‐Wistedt Breakdown of academic impact, for papers by Steven K. Secunda Breakdown of academic impact, for papers by Joseph Mendels
Rankless by CCL
2026